CITI-002

· Citius Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CITI-002, covering 2023-08-31 to 2023-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids [Phase 2]